1.25
price up icon2.46%   0.03
after-market 시간 외 거래: 1.26 0.01 +0.80%
loading
전일 마감가:
$1.22
열려 있는:
$1.24
하루 거래량:
282.19K
Relative Volume:
0.33
시가총액:
$228.03M
수익:
-
순이익/손실:
$52.50M
주가수익비율:
42.96
EPS:
0.0291
순현금흐름:
$-4.13M
1주 성능:
+6.84%
1개월 성능:
-3.10%
6개월 성능:
+17.92%
1년 성능:
+75.81%
1일 변동 폭
Value
$1.22
$1.27
1주일 범위
Value
$1.14
$1.28
52주 변동 폭
Value
$0.2556
$3.09

Tevogen Bio Holdings Inc Stock (TVGN) Company Profile

Name
명칭
Tevogen Bio Holdings Inc
Name
전화
646-807-8832
Name
주소
15 INDEPENDENCE BOULEVARD, SUITE 410, WARREN
Name
직원
17
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
TVGN's Discussions on Twitter

TVGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TVGN
Tevogen Bio Holdings Inc
1.25 228.03M 0 52.50M -4.13M 0.0291
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-04 개시 D. Boral Capital Buy

Tevogen Bio Holdings Inc 주식(TVGN)의 최신 뉴스

pulisher
Jun 19, 2025

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Sees Large Growth in Short Interest - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target DiscoveryRIVER COUNTRY - RIVER COUNTRY - NEWS CHANNEL NEBRASKA

Jun 18, 2025
pulisher
Jun 18, 2025

Tevogen Uses AI To Advance EBV-Specific T Cell Therapy Toward Clinical Trials - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

Breakthrough: AI Technology Accelerates EBV Cancer Treatment Discovery at Tevogen - Stock Titan

Jun 18, 2025
pulisher
Jun 11, 2025

Tevogen Bio (NASDAQ:TVGN) Given Buy Rating at D. Boral Capital - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Tevogen Bio Expands Headquarters To Support Growth In AI And Generics & Biosimilars Initiatives - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Tevogen expands headquarters in Warren, New Jersey - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Tevogen’s lease agreement will double headquarters footprint at Warren HQ - ROI-NJ

Jun 10, 2025
pulisher
Jun 09, 2025

Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives - The National Law Review

Jun 09, 2025
pulisher
Jun 09, 2025

Tevogen Bio Expands Headquarters to Enhance R&D and Operational Efficiency with Support from Microsoft - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Tevogen Transforms into AI Powerhouse: $36B Revenue Target as Company Doubles HQ Size - Stock Titan

Jun 09, 2025
pulisher
Jun 04, 2025

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Shares Purchased by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

tevogen bio expands office lease in new jersey with key amendment - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Tevogen Bio Expands Office Space in New Jersey - TipRanks

Jun 03, 2025
pulisher
May 30, 2025

Tevogen Bio expands AI in immunotherapy development By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Tevogen Bio expands AI in immunotherapy development - Investing.com India

May 30, 2025
pulisher
May 30, 2025

Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships - The Manila Times

May 30, 2025
pulisher
May 30, 2025

Tevogen Bio Holdings Inc. Unveils Tevogen.AI™ Initiative to Enhance Immunotherapy Development with Advanced AI Technologies - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Tevogen Details its Artificial Intelligence Initiative, - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered ... - Bluefield Daily Telegraph

May 30, 2025
pulisher
May 30, 2025

Tevogen Teams Up with Microsoft to Transform Healthcare: New AI Platform Targets $5T Industry - Stock Titan

May 30, 2025
pulisher
May 30, 2025

Tariff Twist and PCE Ahead—Markets Hold Key Support - The Globe and Mail

May 30, 2025
pulisher
May 30, 2025

This Raytheon Rival Is on Track to Hit New 52-Week Highs - The Globe and Mail

May 30, 2025
pulisher
May 30, 2025

PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla - The Globe and Mail

May 30, 2025
pulisher
May 30, 2025

Is IonQ Stock a Buy Now? - The Globe and Mail

May 30, 2025
pulisher
May 29, 2025

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Sees Large Drop in Short Interest - Defense World

May 29, 2025
pulisher
May 27, 2025

4 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - The Globe and Mail

May 27, 2025
pulisher
May 25, 2025

Tevogen Peports Plans to Increase the Target Population for TVGN 489 - Insider Monkey

May 25, 2025
pulisher
May 24, 2025

Tevogen expands target for COVID treatment to seniors By Investing.com - Investing.com India

May 24, 2025
pulisher
May 23, 2025

Tevogen expands target for COVID treatment to seniors - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Tevogen Bio Plans to Expand Specialty Care Pipeline to - GlobeNewswire

May 23, 2025
pulisher
May 23, 2025

Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

Tevogen to Update on Robust Portfolio Assets, Business - GlobeNewswire

May 23, 2025
pulisher
May 22, 2025

Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Tevogen Bio Holdings Inc. to Provide Key Updates Ahead of Annual Meeting on June 23, 2025 - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited ... - Bluefield Daily Telegraph

May 22, 2025
pulisher
May 22, 2025

Tevogen Unveils Massive $10B Portfolio Valuation and AI Expansion Ahead of Critical June Meeting - Stock Titan

May 22, 2025
pulisher
May 20, 2025

Nvidia-Foxconn AI Alliance Could Disrupt the Supercomputer Market—What’s at Stake for Investors - The Globe and Mail

May 20, 2025
pulisher
May 16, 2025

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Stock Position Raised by Barclays PLC - Defense World

May 16, 2025
pulisher
May 14, 2025

Tevogen Bio Holdings Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 13, 2025

Tevogen Bio (NASDAQ:TVGN) Given “Buy” Rating at D. Boral Capital - Defense World

May 13, 2025
pulisher
May 12, 2025

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Tevogen Bio Positions Itself as a Leader in Cost-Efficient Healthcare Amid Global Pharmaceutical Competition - Nasdaq

May 12, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Has $40,000 Stake in Tevogen Bio Holdings Inc. (NASDAQ:TVGN) - Defense World

May 08, 2025

Tevogen Bio Holdings Inc (TVGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):